Quarter of slower, but positive returns What doesn’t kill you makes you stronger – this aphorism from German philosopher Friedrich Nietzsche is clearly playing out in the ongoing bull market. During the Jan-Mar 2021 quarter, our stock markets delivered the …
A rally for all seasons The quarter under review i.e. Oct-Dec 2020, was a great one for equities globally, including our stock markets. Our fund NAV rose 14.7%, following up on a similar performance during the previous quarter. This performance …
Plethora of challenges in our short journey so far We have completed 3 years of managing our long only AIF. Notably, Nifty delivered 4.7% CAGR, which is amongst the poorest of any similar period. In fact, Mid and Small cap …
A quarter of partial recovery We started the quarter in the abyss but ended with a reasonable degree of hope and expectation. Our fund NAV rose 19.4% during the quarter under review, slightly lagging the benchmark BSE 500. The recovery …
Contagion led destruction A global pandemic like no other seen in the past century has wiped out over 30% of market cap across markets. In less than a month, most stock markets have capitulated from historic peaks to multi-year lows. …
Yet another quarter of divergence The quarter under review has been singularly challenging for us. While benchmark BSE 500 rose 3.3%, our fund NAV declined 0.1%. An aberration we opine, but will get to that analysis later. Most of the …
Decent show amidst high volatility We completed 2 years of active fund management this September. Since inception, NAV is up 18.1%, bettering benchmark BSE500, which was up 9.9%, and significantly ahead of small and mid-cap indices. During the first year, …
Tepid end to lackluster quarter This was expected to be a defining quarter, one way or the other. However, other thancustomary volatility, our stock markets have gone nowhere. Economic slowdown and trade war largely negated factors such as election outcome …
A remarkable quarter Despite faced with the toughest market situation yet of our short tenure, we closed the quarter with 4.7% accretion to fund NAV. This was ignificantly better compared to all major indices including benchmark BSE 500 (which was …
